1. 274 Development of a novel marker for detection of degradation and formation of fibronectin in cancer ex vivo models. (September 2015) Authors: Bager, C.L.; Bay-Jensen, A.C.; Leeming, D.J.; Gudmann, N.S.; Karsdal, M.; Balslev, I.; Christiansen, A.P.; Høgdall, E.; He, Y. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A novel, high sensitivity marker of cartilage formation was developed and tested in a phase ii clinical trial of PTH. (April 2017) Authors: Luo, Y.Y.; He, Y.; Byrjalsen, I.; Henriksen, K.; Gudmann, N.S.; Mobasheri, A.; Hansen, G.; Karsdala, M.; Bay-Jensen, A.C. Journal: Osteoarthritis and cartilage Issue: Volume 25(2017)Supplement 1 Page Start: S106 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB0086 PTH Stimulates Cartilage Formation in Low Turnover Patients – a Possible Systemic Anabolic Treatment for OA?. (9th June 2015) Authors: Siebuhr, A.S.; Gudmann, N.S.; Musa, K.; Kehlet, S.; Hansen, G.; Byrjalsen, I.; Andersen, J.; Bihlet, A.; Christiansen, C.; Karsdal, M.A.; Bay-Jensen, A.-C.; Henriksen, K. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 919 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. AB0174 Changes in Type VI Collagen Degradation Reflect Response To Treatment in Rheumatoid Arthritis Patients Treated with Tocilizumab. (15th July 2016) Authors: Thudium, C.S.; Gudmann, N.S.; Musa, K.; Karsdal, M.A.; Bay-Jensen, A.-C. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 956 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. AB0235 Effect of Tocilizumab Combined with Methotrexate on Blood-Based Neoepitope Biomarkers in The Radiate Study. (15th July 2016) Authors: Juhl, P.; Siebuhr, A.S.; Thudium, C.; Gudmann, N.S.; Karsdal, M.; Bay-Jensen, A.-C. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 978 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. AB0671 Degradation of Isomerized Type II Collagen May Serve as A Discriminative Biomarker of Inflammation Mediated Joint Destruction in Rheumatic Diseases. (15th July 2016) Authors: Thudium, C.S.; He, Y.; Gudmann, N.S.; De Vlam, K.; Lories, R.; Hirata, S.; Tanaka, Y.; Karsdal, M.A.; Bay-Jensen, A.-C. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 1134 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Degradation of isomerized type II collagen – A highly specific marker for joint destruction that can distinguish between different rheumatic pathologies. (April 2016) Authors: Thudium, C.S.; He, Y.; Gudmann, N.S.; Hirata, S.; Petersen, K.K.; Arendt-Nielsen, L.; Lories, R.J.; Simonsen, O.; de Vlam, K.; Tanaka, Y.; Karsdal, M.; Bay-Jensen, A.C. Journal: Osteoarthritis and cartilage Issue: Volume 24(2016)Supplement 1 Page Start: S75 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Effects of musculoskeletal related growth factors on cartilage extracellular matrix formation. (April 2016) Authors: Kjelgaard-Petersen, C.; Reker, D.; Gudmann, N.S.; Gigout, A.; Siebuhr, A.; Karsdal, M.A.; Michealis, M.; Ladel, C.; Bay-Jensen, A. Journal: Osteoarthritis and cartilage Issue: Volume 24(2016)Supplement 1 Page Start: S155 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Ex vivo tissue cultures of bone, cartilage and synovium with corresponding biomarkers: A tool box for drug discovery. (April 2015) Authors: Thudium, C.S.; Siebuhr, A.S.; Kjelgaard-Petersen, C.F.; He, Y.; Gudmann, N.S.; Henriksen, K.; Christiansen, T.; Karsdal, M.A.; Bay-Jensen, A.C. Journal: Osteoarthritis and cartilage Issue: Volume 23(2015)Supplement 2 Page Start: A267 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. FRI0089 C4M – A Blood-Based Biomarker – Is An Objective Marker of Disease Activity and Radiographic Status: Replication and Validation or Previous Findings in The Oskira Rheumatoid Arthritis Studies. (15th July 2016) Authors: Gudmann, N.S.; Platt, A.; Karsdal, M.; Bay-Jensen, A.C. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 459 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗